Inscription Ouverte


Archive
08/06/2018
21/08/2018

NEW DIABETIC AGENTS... WHAT TO CHOSE?

  • Review current therapies to treat type 2 diabetes mellitus with emphasis on new agents
  • Review new landmark cardiovascular safety trials
  • Review 2018 CDA guidelines with respect to new targets for glycemic control
  • Provide some framework for choosing amongst the different agents
  • Review insulin initiation and the new insulins
Natasha Garfield, MDCM, FRCP(C)
diabetes, new medications, new insulins



[ Toutes ] [ Nouvelles ]
Événements en direct

Grands Événements

Événements Accrédités
 

 

 © 2002-2018 Bureau Développement Professionnel Continu (DPC),
Faculté de médecine, Université McGill